In multiple myeloma (MM) cells, the cytoplasmic proteoglycan Serglycin is uniquely secreted, rather than being retained intracellularly as in healthy hematopoietic cells and other diseased cells. This evidence concerns the gene SRGN and Miyoshi myopathy.